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1. Introduction 
1.1 History 
Total Hip Arthroplasty (THA) has been hailed the ‘The operation of the century.’ (1) While 
the prevalence of coxarthrosis is relatively unchanged from ancient times, attempt at 
surgical treatment are relatively recent Themistocles Gluck is credited with performing the 
first hip arthroplasty in Germany in 1891. It was a hemi arthroplasty and he used an ivory 
femoral head. Early attempts at the turn of the 20th century focused on interpositional 
arthroplasty using a variety of tissues which included skin, fascia lata, and pig’s bladder (1)! 
Also during this period Dr Ban saw, then chief of orthopaedics at the Mandalay General 
hospital in Burma, used hand made ivory components for patients with femoral neck 
fractures. He presented a report of his first 300 cases in 1969. His patients were aged 
between 24 and 87 years old. Eighty eight per cent returned to sports and bicycle riding 
within weeks post surgery. 
The dawn of the modern era of hip arthroplasty was heralded by the vitallium mould 
design of Smith-Petersen. Wiles subsequently developed and inserted the first THA in 1938 
in the UK. 
The next most significant step was made by British surgeon Sir John Charnley. In the 1960’s 
he introduced several pivotal concepts including the low friction arthroplasty, the use of 
polymethyl methacrylate cement as a grout and the use of high density polyethylene as a 
bearing surface. While several of Charnley’s principles and techniques have evolved, the 
principles he proposed remain relatively unchallenged. 
Arguably the most important modern advancement in arthroplasty surgery has been the 
establishment of joint registries. These provide invaluable data on survival, complications 
and can help to establish standards for practice. The Swedish joint registry is the most 
established of these. Much of the long term survival  data for specific types of implants and 
fixation methods are extracted from this database. Registries are now in existence in most 
countries including the UK. The American Joint Replacement Registry (AJRR) is currently in 
the process of being formalised. 
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2. Indications 
The main indication for total hip arthroplasty is pain secondary to primary or secondary 
osteoarthritis (2), and has remained largely unchanged for the past few decades. Results 
from the Swedish Registry show the mean age for THR was about 70 years old with a 
decrease in age seen in men while an increase was noted in women. Recent trends have seen 
a widening of the indications for performing total hip arthroplasty to include rheumatoid 
arthritis in cases of failed medical management. Such patients are often younger compared 
with elderly patients who commonly present with osteoarthritis and trauma (2). Other 
indications include avascular necrosis, metastatic disease and ankylosing spondylitis.  
The use of total hip arthroplasty in treating femoral neck fractures has, and continues to generate 
controversy. There is a move towards basing the surgical management on patient-related, rather 
than diagnosis related approach as a reflection of this heterogeneous group of patients. For 
example, fit elderly patients with pre-existing symptomatic osteoarthritis who sustain a femoral 
neck fracture should be considered for total hip arthroplasty rather than internal fixation. 
There are a number of studies that support this approach. Blomfeldt  et al (3) conducted a 
randomised control trial comparing the outcome of patients with displaced neck of femur 
fractures, who are relatively fit, active and indecently mobile, treated with internal fixation 
or total hip arthroplasty. They treated one hundred and two patients with a mean age of 
eighty years. Forty nine patients where randomised to THR and fifty three underwent 
internal fixation. Their results showed similar mortality rate of 25% at four year follow-up 
but a better functional outcome, lower complication and re-operation rate in the total hip 
arthroplasty group compared to the internal fixation group. Another randomized 
prospective trial involving two hundred and seven patients by Keating et al (4), treated 
patients with internal fixation, hemiarthroplasty and total hip arthroplasty. Their results 
showed better functional outcome in the THA group in comparison to the other groups. 
Cost analysis also showed a higher rate for the internal fixation group due to higher re-
operation rate but no difference between the THR group and hemiarthroplasty group.  
3. Patient expectations 
The widening indications for surgery have influenced the demographics of patients 
undergoing total hip arthroplasty and thus, their expectations. More and more young 
patients are being considered for total hip arthroplasty. These subgroups of patients 
generally tend to be very active and as result place more demands on the replaced hip. Even 
the modern day ‘elderly’ patient has higher expectations in comparison to previous decades 
as patients are offered surgery far earlier owing to improvement in technology and surgical 
technique. This emphasis on meeting patient’s expectation and optimizing subsequent 
function has lead to objective scoring systems such as the Oxford Hip Score (OHS), Harris 
Hip Scores (HHS), the Western Ontario and McMaster University (WOMAC) scoring 
systems being developed and more recently in the UK patient related outcome measures. A 
study by Mancuso et al looking at the fulfilment of patient’s expectation showed that only 
43% patients (of 405) thought their pre-operative expectations where fulfilled fully. They 
showed that younger patients and those with a BMI of lower that 35kg/m2 had a greater 
proportion of their expectations fulfilled (5). 
The modern day THR, however, patient is more likely to be obese compared to previous 
generations and may develop early failure as a result. However, advances in implant design and 
tribology have increased the Orthopaedic Surgeon's armamentarium in facing these challenges. 
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4. Surgical technique 
While the ideal approach for THA is as yet undecided, several approaches have been 
described and are used in routine practice. While no revolutionary changes have been made 
to the classically described techniques, significant refinements and advances have occurred 
particularly with the development of minimally invasive approaches for THA and the 
instruments to facilitate these approaches. 
Previous techniques described include the lateral (Hardinge) (6), anterior (Smith-Petersen) 
(7), posterior (Moore or southern) and medial approaches (8), each with its unique risks and 
benefits. The approach most commonly used in the UK is the posterior (57%) followed by 
the anterolateral approach (37%) according to the United Kingdom National Joint Registry 
(UK NJR) (9). Personal communication with members of the British Hip Society has revealed 
that the posterior approach is favoured by the majority of specialist hip surgeons. 
Results from the Swedish Arthroplasty Register (10) have suggested that the posterior 
approach is being performed less frequently (52% in 2008 vs 65% in 1992) likely due to an 
increased incidence of dislocation particularly with the minimally invasive posterior 
approach. The surgical approach used in our unit is the posterior approach which is 
described below after a description of the original procedure: 
This approach, popularised by Moore, is also called the southern approach. It consists of a 
10-15 cm incision centered on the posterior aspect of the greater trochanter. This is deepened 
through the fascia lata. The gluteus maximus is split along the line of the incision. This along 
with internal rotation of the hip allows visualisation of the common insertion of the short 
external rotators on the posterior aspect of the proximal femur. Also visible is a layer of fat 
which contains the sciatic nerve at its center. This must be protected. Internally rotating the 
hip moves this nerve out of the operative field. 
Once the tendons are identified, stay sutures are placed in the tendons of the piriformis and 
obturator internus. These are then detached from the femur at their point of attachment. 
Deep to this layer is the posterior capsule. Once this is incised further internal rotation will 
lead to dislocation of the hip joint. Repair of the posterior structures is not routinely 
recommended with this description. 
Early criticism of the posterior approach stemmed from several reports of higher dislocation 
rates in patients treated with this technique (11, 12). Many authors using this contemporary 
posterior approach have recorded very low dislocation rates and addition of posterior capsular 
repair has reduced the dislocation rates to <2% (13). Also when compared to the lateral 
approach, the incidence of postoperative abductor lurch is very low with posterior approach. 
5. Dislocation rates 
Despite early reports, studies over the last decade have shown that the incidence of 
dislocation decreases substantially if a posterior capsular repair is performed.  
Masonis and Bourne (14) reviewed fourteen studies comprising 13,203 patients. Overall 
there was a six times increased rate of dislocation in patients treated with a posterior 
approach when compared to the trans trochanteric , anterolateral and direct lateral 
approaches. In the group which had a posterior approach dislocation rates among those 
patients who had a capsular repair was 2.03% compared to 3.95% in the group which had no 
repair performed. These results were pooled from multiple surgeons however and such 
heterogeneity has been associated with poor results, particularly among junior surgeons (15). 
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In a well designed single surgeon series Wilson et al (16) showed that dislocation rates 
reduced from 3.1% to 0.7% after a posterior repair was performed. Similar results have been 
reported by other authors (17, 18, 19) including Suh et al who reported that repair of the 
posterior structures reduced their dislocation rates in revision THA from 10% to 1.9% (13). 
These results are summarised in Table 1. 
 
   Dislocation rates related to approach 
Authors Date Number 
in study
Posterior Anterolateral Posterior 
with repair 
Direct 
Lateral 
Palan et al 2009 
(Prospective) 
1089 2.3% 2.1% _ _ 
Tsai et al 2008 
(Retrospective) 
204 6.38% _ 0% _ 
Kwon et al 
 
2006 
(meta analysis) 
_ 4.46% 0.75 0.49% 0.43% 
Wilson et al 2005 
(Retrospective) 
2213 3.9% _ 0.9% _ 
Suh et al 2004 
(Prospective) 
346 6.4% _ 1% _ 
Masonis 
and Bourne 
2002 
(Review) 
13,203 3.95% 2.18 2.03 0.55 
Table 1. Dislocation rates after the posterior approach- Summary of results 
6. Our current technique (figures 1-5) 
In our unit the posterior approach is used for both primary and revision THA. For primary 
THA a minimally invasive technique is routinely performed and is described below.  
The patient is placed in a lateral decubitus position. The tip of the greater trochanter and the 
posterior boarder of the proximal femur are identified. A 10 to 12cm incision centered on the 
posterior one third of the tip of the greater trochanter  is made which extends 5cm above 
and 5cm below this point. The incision proximal to the greater trochanter is angled 
backwards by 30 to 40 degrees. The incision is deepened to the level of the fascia lata which 
is also incised. The gluteus maximus is split along the line of the incision revealing the 
trochanteric bursa which is divided in line with the incision but preserved. Internal rotation 
of the hip at this stage brings the posterior aspect of the greater trochanter with its attached 
short external rotators into the operative field. At this stage we use a gauze swab to wipe the 
bursal tissue and fat off of the short external rotators (SER) attachment gently downward. 
This action exposes the tendons of short external rotators- from proximal to distal 
piriformis, superior gemellus, obturator internus, inferior gemellus and quadratus femoris- 
and moves the sciatic nerve away from the operative field. Next superior border piriformis 
tendon is identified and a curved retractor is placed under the gluteus minimus but above 
the superior border of piriformis tendon. Stay sutures are placed in the common tendon of 
the SER muscles and the underlying capsule (Figure 3). The short external rotators, along 
with posterior capsule, is then divided with diathermy at its point of attachment to the 
greater trochanter. Then posterior dislocation of the hip is performed by adduction, flexion 
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and internal rotation of femur. Once the procedure is completed the short external rotators 
and the capsule is reattached via drill holes to the posterior part of greater trochanter. 
 
 
Fig. 1. Landmarks for the skin incision 
 
 
Fig. 2. Fat and bursa moved away from operative field. This protects the sciatic nerve. 
Fat surrounding the  
sciatic nerve 
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Fig. 3. Stay sutures in the short external rotator (SER) tendons 
 
 
Fig. 4. Dislocated femoral head 
www.intechopen.com
 Hip Arthroplasty 
 
33 
 
Fig. 5. Post reduction of THA 
7. Minimally Invasive Surgical (MIS) approaches  
Over the last decade minimally invasive techniques have drawn much attention. These 
methods represent a refinement rather than a revolution of standard approaches. They have 
been described for the anterior, posterior and lateral approaches. By definition a minimally 
invasive approach infers an incision length of ≤ 10cm. 
Views and conclusions about MIS THA are conflicting but overall this is accepted as safe, 
but not better nor a replacement for established surgical approaches. This view is supported 
by level I evidence. In the UK the National Institute for Health and Clinical Evidence has 
recommended that the MIS posterior approach is safe but the Swedish Registry suggests 
that there is an increased incidence of dislocations with this approach which accounts for its 
decreasing use. 
MIS THA has been extensively studied in the literature. Dorr et al (20) showed that while 
immediate post operative pain control and mobility were improved in the MIS group, there 
was no difference between this group and those in whom a conventional approach was used 
at 6 weeks and beyond. Recent level 1evidence (21) has revealed that when comparing the 
MIS anterolateral, classic posterior and MIS posterior approaches found similar results. This 
study also found that patients who had the posterior MIS approach had favourable 
outcomes when compared to the MIS anterolateral approach. Pagnano et al (22) also found 
that patients receiving the posterior MIS approach walked, achieved independence from 
assistive devices and returned to activities of daily living before those treated using a 2 
incision approach. 
While opinions on the clinical benefits of MIS THA seem to be in agreement, these differ on 
the overall benefits of this approach. Reininga et al (23) in their review, concluded that MIS 
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THA is a safe procedure although there is no firm evidence of functional benefit. Smith et al 
(24) reviewed 2849 hips, however, and found a significantly elevated risk of transient lateral 
femoral cutaneous nerve palsy in the group treated with the MIS technique, again with no 
functional benefits. 
What has not been clarified in this area is the ‘ideal’ MIS approach, whether specialised 
instruments help, the group of patients best suited for this procedure and the learning curve 
for this technique. 
8. Technology 
A number of advances have been made since Sir John Charnley pioneered the Low Friction 
Arthroplasty in the 1960s. His design consisted of a stainless steel mono polar femoral stem 
and a polyethylene acetabular cup both fixed using polymethyl methaacyrlate bone cement. 
There are currently more than 100 hip stems and cups respectively submitted to the 
Orthopaedic Data Evaluation Panel (ODEP) for assessment, all of which has variable 
designs and choices of bearing surfaces. 
The National Institute of Clinical Excellence (NICE) which issues guidance on selection of 
prosthesis advises that the best prosthesis should have a revision rate of 10% or less at ten 
years, demonstrable by long term viability studies. Cemented prosthesis has the longest 
viability studies but a number of uncemented prosthesis have passed the ten year mark with 
good results.  
The trend is to use cemented prosthesis in elderly patients with poor bone quality, while 
uncemented stems are more commonly used in younger more active patients or those with 
good bone quality in general.  
Well fixed cemented components depend primarily on two interfaces; implant cement 
interface and cement-bone interface. Adequate fixation of both interfaces is crucial to the 
long term survival of the prosthesis as the load is transmitted via the prosthesis to the 
cement-bone interface. Any weakness in either may lead to early failure. Considerable 
advancement has been made from the first generation cementing technique (finger packing, 
no cement gun, no cement restrictor or canal pressurization) to the third generation 
(elimination of air bubbles via vacuum preparation, stem centralizer and femoral canal 
pressurization) thus improving the stability of well fixed cemented implants. In addition, 
modern day cemented stems are modular, allowing for a range of femoral heads to be fixed 
for optimal soft tissue balancing and stability. 
Uncemented implants coated with hydroxyapatite have either porous coated or grit-blasted 
surfaces and depend on ‘biologic’ fixation of bone by bony interdigitation into the stem. A 
well fixed uncemented stem requires cortical seating into the femoral canal. Some 
uncemented acetabular implants offer added security of screw fixation for improved 
stability. 
9. Bearing surfaces 
An ideal bearing surface has the following characteristics. (25) 
1. low coefficient of friction 
2. resistant to third body damage and wear 
3. generates small amount of particles 
4. has low cellular reaction to wear debris 
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A variety of significant advancements in bearing surfaces has been made since the dawn of 
modern era of hip arthroplasty. Figure 6 outlines the major advances. 
Bearing surfaces can be split into two broad groups: 
1. Hard on soft bearings 
2. Hard on hard bearings   
 
Teflon, Stainless steel metal-metal
Metal- UHMPWPE, Ceramic-Ceramic
Ist Generation highly crossed-linked
2nd Generation highly crossed-linked
1950
1960
1970
1980
1990
2000
 
Fig. 6. Major advances in bearing surfaces. 
10. Hard on soft bearings 
The ultra high molecular weight polyethylene (UHMWPE) acetabular cup was introduced 
in 1962 coupled with metallic heads to form hard-on-soft bearing surface. UHMWPE 
consists of several long chains of monomer ethylene which serves to transfer load more 
effectively to the polymer backbone by strengthening intermolecular interactions. Early 
wear was a major problem with the early prostheses, particularly with larger bearing 
surfaces. The third body particle thus generated enters the effective joint space and 
stimulates a foreign body response resulting in osteolysis which is mainly mediated by 
macrophages (26). PE wear is related to three main factors; implant geometry and material 
properties, sterilization and shelf-life. Initially, it was widely accepted that the osteolysis 
was due to delayed reaction to bone cement (PMMA), this erroneous belief lead to the 
development of uncemented prosthesis such as the Austin Moore prosthesis. This change 
did not positively affect the wear profile of the PE cup. 
One of the best advances to UHMPE liner use was the advent of highly crossed linked PE 
liner introduced in 1998. This is achieved by low dose gamma or electron beam radiation 
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and thermal treatment to increase their oxidation resistance. Its advantages include 
increasing resistance to abrasive and adhesive wear thereby improving bearing wear rates. 
Another example of a hard-on-soft surface is ceramic on PE but is not a widely used 
combination.  
11. Hard on hard bearings 
Wear-particle related osteolysis around THA components and subsequent failure rates lead 
to the development of other bearing surfaces such as metal-on-metal articulations. Cobalt-
Chrome is the commonest metal alloy used. One of the main theoretical advantages of hard 
on hard bearing surfaces is reduction in osteolysis (27) by generating less wear particles. In 
addition, the particle size generated is also smaller (0.015-0.12um) compared to the particle 
size range (0.2-7um) that has been shown to trigger osteolysis. The first generation metal-on-
metal hip arthroplasty showed a low rate of wear and long term results demonstrated that 
failure was due implant design rather than wear particles (28). 
Other advantages of metal on metal surfaces include a higher scratch resistance and larger 
bearing components which increases the excursion distance, the distance needed to travel 
before the neck impinges and dislocate, due to the increase in head to neck ratio. This is 
particularly advantageous in revision surgery for dislocation.  
Metal on metal bearings, however, are not completely biologically inert. A number of soft 
tissue reactions have limited its use. These include metallosis and aseptic lymphocytic 
vasculitis associated response (ALVAL). There is an increased risk for these adverse tissue 
reactions in females, smaller femoral head bearings and obesity (29). 
Another type of hard on hard surfaces are ceramic bearings, first introduced in the mid 60s. 
They are harder than metal and have a lower wear rate especially when coupled with its 
self. In addition, the wear particles generated are biologically inert, eliminating the concerns 
of sift tissue reactions seen with metal on metal bearings. The main disadvantage, however, 
is its low resistance to fracture and squeaking, particularly seen in the taller, younger and 
heavier patients. Like polyethylene bearings, ceramic bearing surfaces have improved since 
the first generation implants which were more susceptible to fracture.  
There are two types of ceramic bearings; alumina and zirconia. Zirconia femoral heads 
coupled with PE leads to accelerated wear and early failure and is thus not recommend 
coupling these two components. 
12. Results 
Total hip arthroplasty remains one of most successful operations in terms of cost 
effectiveness and symptom relief for patients. 
The best prosthesis should have a demonstrable long survivorship and low revision rates. 
These attributes are best shown by National Joint Registries which not only provide early 
warning of failures but show cumulative experience of surgeons while eliminating potential 
bias by the innovator. The main goals of national joint registry is three fold; defining the 
epidemiology of a particular patient population, providing timely information about 
outcome and identifying risk factors for poor outcomes (30). The Swedish hip registry was 
the first national joint registry introduced in 1979. Its main goal was to describe the 
outcomes of primary hip replacements and to report complications. Since its inception, 
many other countries have started national joint registries. Many of these registries provide 
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the Orthopaedic community with the results of the oldest and newest prosthesis in the 
market while keeping track of modifications and innovations. 
Charnley’s cemented femoral stem has undergone a number of modifications since its 
inception, including changing from a monoblock to modular stem while retaining the stem 
geometry. The stem was later modified into the Elite-plus stem (Depuy, Warsaw, Indiana, 
USA) by undercutting the flange, reducing the diameter and addition of a stem centralizer. 
Data for the Swedish hip registry shows favorable results for the original stems; the cohort 
operated on from 1979 to 1989 had a twenty-one-year survival rate of 81.7% based on 18,607 
observations. The more recent cohort, (1990 to 2000), had a ten-year survival rate of 93% 
based on 20,162 observations (2). Similar results have been reproduced in other centres. 
Shculte et al showed 90% survivorship of the stem using revision as endpoint in 322 hips 
(31). The modern day Charnley Elite Plus stem also has favourable medium term results as 
shown in Kim YH et al prospective study in 194 young hips, with a mean age of 49.1 which 
demonstrated a 12 years survivorship of 99% using revision surgery as end point (32). 
The Exeter femoral stem was introduced around the same time as the Charnley prosthesis 
and has also undergone a number of modifications since its inception. It is a double tapered, 
highly polished stem. The Swedish hip register showed a 7 year survival of 98.1% in 4,769 
implants. While Carrington et al showed 100% and 90.4% for the femoral and acetabular 
components, respectively at 17 years using aseptic loosening as an endpoint (33). 
Some uncemented femoral prosthesis, such has the Furlong hip replacement (Joint 
replacement Instrumentation limited, London. United Kingdom) also have favourable 
results. The Furlong stem is titanium, hydroxyapatite ceramic coated stem first introduced 
in 1985. Good short to medium term results has been reported in literature (34). The longest 
follow-up in literature is 21yrs which shows comparable results to previously mentioned 
cemented stems, 97.4% with revision for any reason as endpoint.  
The Corail stem is another uncemented stem with long term results. First introduced in 
1986, it is tapered HP coated stem made from titanium alloy. Since inception, it had been 
modified to a collarless stem and recently (2004) the neck was made slimmer and the taper 
shortened. The Norwegian Hip Registry shows 97% survivorship at 15 years using revision 
for any cause as endpoint (35). 
These comparable results show that both cemented and uncemented stems can achieve good 
longevity. Its is likely that these results do not only reflect good implant design but also 
increased familiarity with use over the past number of years. Analysis of national hip 
registries show that most of the implants that fail to pass the 10 year mark or with 
survivorship of less that 90% tend to do so early (2 to 3 years) or at medium term (5-8 years). 
13. Current controversies 
A review of current orthopaedic literature would reveal many issues of debate and 
uncertainty. Two issues which currently attract much debate are those of Metal on Metal hip 
resurfacing (MoM HR) and the subject of thromboprophylaxis after THA. These are 
discussed below. 
13.1 Metal on Metal hip resurfacing (MoM HR) 
Resurfacing affected joint surfaces has always intuitively seemed to be correct when 
contemplating surgery for the arthritic hip joint. The Smith Peterson cup arthroplasty is 
considered by some the earliest attempt at surface replacement. Charnley in the early 1950’s 
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performed surface replacements using thin shells of Teflon. Good function was briefly 
restored but severe osteolysis occurred in response to high Teflon wear. 
The next main thrust came in 70’s after THA with conventional stemmed components had 
been introduced and took the form of metal femoral components with high density 
polyethylene sockets. Memorable examples were the ICLH developed in UK by Freeman, 
Wagner contribution from Germany and the THARIES from the USA. Initial results were 
again spectacular but failure developed because of the large amounts of polyethylene debris. 
The poor results of all these attempts led to the concept of resurfacing being abandoned. A 
British surgeon, Derek Mcminn, aware of how well metal on metal bearing surfaces had 
performed based on the results of late revision of both McKee Farrar , Stanmore and Ring 
hips replacements in Birmingham designed a new resurfacing with a metal on metal bearing 
surface with the metallurgy based on the results that had been learnt from these earlier 
metal on metal designs. 
Contemporary MoM HR was thus pioneered in the UK by McMinn. Improved design, 
metallurgy and advances in engineering resulted in the design of the Birmingham Hip 
Resurfacing prosthesis. Original designs have been used in the UK since 1991 and approved 
by the United States Food and Drug Administration in 2006. Proposed advantages of this 
prosthesis include improved stability due to its large diameter, improved proprioception, 
improved range of motion and return to function, bone conservation and relative ease of 
revision. Early results have been encouraging but data from the UK National Joint Registry 
(NJR) suggest that MoM HR prostheses have relatively high early failure in certain groups 
and therefore revision rates. There have been concerns about increases blood levels of cobalt 
and chromium ions in patients with these prostheses in situ as well as the occurrence of 
periarticular destructive soft tissue lesions- so called pseudotumors. 
Revision of failed MoM HR to stemmed modular MoM THA has also occurred with 
increasing frequency as a result of the proposed ‘ease of revision.’ These prostheses pose a 
new and unique issue to the arthroplasty community as there seems to be concerns with 
these components which are similar to those for MoM HR. Recent guidance from the British 
Hip Society (March 2011) has suggested that patients with these components be followed 
more closely than those with standard THA as the risk of adverse effects seem to be similar 
to hip resurfacing components. This is currently an area of intense controversy. 
13.2 Throboprophylaxis after THA 
This is the 2nd area of significant controversy with unique issues in the UK and USA. This 
issue creates such debate that we have presented a brief review of current evidence before 
discussing the controversy surrounding it. 
13.3 Deep vein thrombosis (DVT) and Pulmonary embolism (PE) after THA 
The incidence of radiologically detected DVT after lower limb arthroplasty surgery is 30-
60% (for the entire limb) and 10- 20% for proximal segment veins. Symptomatic PE occurs in 
1-2% of this group (36). The rate of fatal PE is 0.1-0.2% (37). Risk factors for DVT and PE 
include obesity, American Society of Anaesthesiologist’s grade 3 or above, revision surgery, 
dementia and renal and cardiovascular disease. 
A meta analysis of DVT prophylaxis regimens found that the rate of DVT’s increased 2-3 
fold if no thromboprophylaxis was used. The lowest rates of proximal DVT’s occurred when 
warfarin and low molecular weight heparin (LMWH) were used. The incidence of 
symptomatic PE’s was decreased by warfarin, pneumatic compression devices (PCD’s) and 
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LMWH. The rate of fatal PE was unaffected. Major bleeding occurred in patients who 
received low dose heparin (38). This review concluded that warfarin was the best overall 
single agent. 
When used as part of a multimodal approach aspirin has been found to have the same 
efficacy as warfarin (39). Multimodal approaches address each aspect of Virchow’s Triad. It 
includes the use of regional anaesthesia, PCD’s, chemical agents and early patient 
mobilisation. This approach has reduced the rate of asymptomatic and symptomatic DVT to 
5.2% and 0.4% respectively (20). These authors found that patients on warfarin had a 
significantly increased incidence of wound haematomas compared to those on aspirin. 
Sharrock et al (40)reviewed >15000 patients and found a higher all cause mortality and 
increased incidence of non fatal PE’s in those receiving contemporary potent anticoagulants 
(including LMWH, Fondaparinux and Rivaroxiban) and Warfarin than groups who received 
multimodal therapy. 
This evidence seems to suggest that potent anticoagulants are not ideal in patients 
undergoing THA and conflicts with national guidance in the United Kingdom. It must be 
emphasized that patients should undergo pre operative assessment prior to a decision on 
the choice of thromboprophylaxis agent is made.  
14. United Kingdom 
A House of Commons Select Committee Report 2004- 2005 suggested that 2500 preventable 
deaths occurred annually as a result of deep venous thrombosis (DVT). It led to the 
publication of guidance by the National Institute for Health and Clinical Excellence (NICE) 
on thromboprophylaxis after THA in 2007. Challenges to these guidelines have arisen and 
include: 
 The mortality figures stated in the parliamentary white paper have overestimated the 
number of deaths 
 Using DVT as a surrogate end point for fatal PE has contributed to this inaccuracy 
 Members of the guidance committee were linked to the pharmaceutical industry 
 Recent evidence has suggested that since the implementation of these guidelines, both 
the amount and duration of pharmacological prophylaxis has increased along with the 
incidence of DVTs and their complications (41). 
15. United States 
In 2004, the American College of Chest Physicians (ACCP) made several recommendations 
for prevention of DVTs and pulmonary embolism which extended to include the 
orthopaedic community. The recommendations included aggressive prophylaxis regimens, 
but were based on the incidence of venographically detected DVTs and used this as a 
‘surrogate’ for fatal pulmonary emboli. In their review process, the ACCP did not consider 
death and fatal PE as suitable end-points.  
Subsequent to the implementation of their guidelines, several centres reported increases in 
their incidences of major complications, symptomatic DVT, PE, wound problems and re-
operation rates, post THA (42).  
These reports led to the development of separate guidelines by the American Academy of 
Orthopaedic Surgeons taskforce in 2006. This group shows prevention of symptomatic PE as 
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opposed to reduction of prevalence of DVT as their end-point. Their guidelines have been 
considered to be much more relevant, and safer, for orthopaedic patients.  
This issue is still unresolved in both regions and continues to elicit debate. 
16. Conclusion 
In summary, total hip arthroplasty is a highly successful procedure in decreasing pain and 
improving  activity across all age groups, genders and geographic regions. Patient 
expectations and demands have increase since the advent of the first generation THA but 
technological advancement is constantly trying to meet this demand. However, there will 
continue to be controversies regarding the ‘ideal’ prosthesis, bearing surface and method of 
fixation. Such controversies may encourage further technical and technological innovations 
as well as an improved understanding of peri-operative issues such as the optimal method 
of VTE prophylaxis.  
Overall, THA will continue to be a highly successful procedure. 
17. References 
[1] Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip 
replacement. Lancet. 2007 Oct 27; 370(9597):1508-19. 
[2] Henrik Malchau, Peter Herberts, Thomas Eisler, Göran Garellick and Peter Söderman. 
The Swedish total hip replacement register. J Bone Joint Surg Am. 2002; 84:2-20. 
[3] Blomfeldt R, Törnkvist H, Eriksson K, Söderqvist A, Ponzer S, Tidermark J. A 
randomised controlled trial comparing bipolar hemiarthroplasty with total hip 
replacement for displaced intracapsular fractures of the femoral neck in elderly 
patients. J Bone Joint Surg Br. 2007 Feb; 89(2):160-5. 
[4] Keating JF, Grant A, Masson M, Scott NW, Forbes JF. Randomized comparison of 
reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty. 
Treatment of displaced intracapsular hip fractures in healthy older patients. J Bone 
Joint Surg Am. 2006 Feb; 88(2):249-60. 
[5] Mancuso CA,  Jout J,  Salvati EA , Sculco TP. Fulfilment of patient’s expectation for total 
hip arthroplasty. J Bone Joint Surg Am. 2009; 91:2073-2078 
[6] Hardinge K. The direct lateral approach to the hip. J Bone Joint Surg Br. 1982; 64(1):17-9 
[7] SMITH-PETERSEN MN. Approach to and exposure of the hip joint for mold 
arthroplasty. J Bone Joint Surg Am. 1949 Jan; 31A (1):40-6. 
[8] Hoppenfeld S, de Boer P. Surgical Exposures in Orthopaedics: The Anatomical 
Approach. 3rd Ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2003. 
[9] http://www-new.njrcentre.org.uk/njrcentre/Default.aspx 
[10] http://www.jru.orthop.gu.se/ 
[11] Mallory TH, Lombardi AV Jr, Fada RA, Herrington SM, Eberle RW. Dislocation after 
total hip arthroplasty using the anterolateral abductor split approach. Clin Orthop 
Relat Res. 1999 Jan; (358):166-72. 
[12] Ritter MA, Harty LD, Keating ME, Faris PM, Meding JB. A clinical comparison of the 
anterolateral and posterolateral approaches to the hip. Clin Orthop Relat Res. 2001 
Apr; (385): 95-9. 
www.intechopen.com
 Hip Arthroplasty 
 
41 
[13] Suh KT, Roh HL, Moon KP, Shin JK, Lee JS.Posterior approach with posterior soft tissue 
repair in revision total hip arthroplasty. J Arthroplasty. 2008 Dec; 23 (8):1197-203. 
Epub 2008 Mar 4. 
[14] Masonis JL, Bourne RB. Surgical approach, abductor function, and total hip arthroplasty 
dislocation. Clin Orthop Relat Res. 2002 Dec;(405):46-53. 
[15] Unwin AJ, Thomas M. Dislocation after hemiarthroplasty of the hip: a comparison of 
the dislocation rate after posterior and lateral approaches to the hip. Ann R Coll 
Surg Engl. 1994 Sep;76(5):327-9. 
[16] R K Wilson; B Mohan; and D E Beverland. REPAIR OF THE SHORT EXTERNAL 
ROTATORS FOLLOWING POSTERIOR APPROACH TO TOTAL HIP 
REPLACEMENT AND ITS EFFECT ON DISLOCATION RATE. Journal of Bone 
and Joint Surgery - British Volume, Vol 87-B, Issue SUPP_III, 268.  
[17] Kwon MS, Kuskowski M, Mulhall KJ, Macaulay W, Brown TE, Saleh KJ.Does surgical 
approach affect total hip arthroplasty dislocation rates? Clin Orthop Relat Res. 2006 
Jun;447:34-8. 
[18] Suh KT, Park BG, Choi YJ. A posterior approach to primary total hip arthroplasty with 
soft tissue repair. Clin Orthop Relat Res. 2004 Jan;(418):162-7. 
[19] Van Stralen GM, Struben PJ, van Loon CJ. The incidence of dislocation after primary 
total hip arthroplasty using posterior approach with posterior soft-tissue repair. 
Arch Orthop Trauma Surg. 2003 Jun;123(5):219-22. Epub 2003 Apr 9. 
[20] Dorr LD, Maheshwari AV, Long WT, Wan Z, Sirianni LE. Early pain relief and function 
after posterior minimally invasive and conventional total hip arthroplasty. A 
prospective, randomized, blinded study. J Bone Joint Surg Am. 2007 Jun;89(6):1153-
60. 
[21] Goosen JH, Kollen BJ, Castelein RM, Kuipers BM, Verheyen CC. Minimally invasive 
versus classic procedures in total hip arthroplasty: a double-blind randomized 
controlled trial. Clin Orthop Relat Res. 2011 Jan;469(1):200-8. Epub 2010 Mar 30. 
[22] Pagnano MW, Trousdale RT, Meneghini RM, Hanssen AD. Slower recovery after two-
incision than mini-posterior-incision total hip arthroplasty. Surgical technique. J 
Bone Joint Surg Am. 2009 Mar 1;91 Suppl 2 Pt 1:50-73. 
[23] Reininga IH, Zijlstra W, Wagenmakers R, Boerboom AL, Huijbers BP, Groothoff  JW, 
Bulstra SK, Stevens M. Minimally invasive and computer-navigated total hip 
arthroplasty: a qualitative and systematic review of the literature. BMC 
Musculoskelet Disord. 2010 May 17;11:92. 
[24] Smith TO, Blake V, Hing CB. Minimally invasive versus conventional exposure for total 
hip arthroplasty: a systematic review and meta-analysis of clinical and radiological 
outcomes. Int Orthop. 2011 Feb;35(2):173-84. Epub 2010 Jun 18. 
[25] Minakawa H, Stone MH, Wroblewski BM, et al. Quantification of third-body damage 
and its effect on UHMWPE wear with different types of femoral head. JBJS Br1998; 
80-B: 894-9. 
[26] YH Zhu, KY Chiu and WM Tang. Review Article: Polyethylene wear and osteolysis in 
total hip arthroplasty. Journal of Orthopaedic Surgery. Vol. 9 No. 1, June 200, 91-99. 
[27] Michael H. Huo, Javad Parvizi, Nathan F. Gilbert. What’s new in hip arthroplasty? J 
Bone Joint Surg Am. 2006; 88:2100-2113 
www.intechopen.com
 Recent Advances in Hip and Knee Arthroplasty 
 
42
[28] Schmalzried TP, Peters PC, Maurer BT, Bragdon CR, Harris WH. Long-duration metal-
on-metal total hip arthroplasties with low wear of the articulating surfaces. J 
Arthroplasty 1996; 11:322-31. 
[29] Ollivere B, Darrah C, Barker T, Nolan J, Porteous MJ. Early clinical failure of the 
Birmingham metal-on-metal hip resurfacing is associated with metallosis and soft 
tissue necrosis. J Bone Joint Surg [Br] 2009; 91-B: 1025-30. 
[30] William J. Maloney National Joint Replacement Registries: Has the Time Come? J Bone 
Joint Surg Am. 2001; 83:1582-1585. 
[31] KR Schulte, JJ Callaghan, SS Kelley and RC Johnston. The outcome of Charnley total hip 
arthroplasty with cement after a minimum twenty-year follow-up. The results of 
one surgeon. J Bone Joint Surg Am. 1993; 75:961-975. 
[32] Kim YH, Kim JS, Yoon SH. Long-term survivorship of the Charnley Elite Plus femoral 
component in young patients. J Bone Joint Surg [Br] 2007; 89-B: 449-54. 
[33] N. C. Carrington, R. J. Sierra, G. A. Gie, M. J. W. Hubble, A. J. Timperley, J. R. Howell. 
The Exeter Universal cemented femoral component at 15 to 17 years, an update of 
the first 325 hips. J Bone Joint Surg [Br] 2009; 91-B: 730-7. 
[34] Singh S, Trikha SP, Edge AJ. Hydroxyapatite ceramic-coated femoral stems in young 
patients, a prospective 10 year study. J Bone Joint Surg [Br] 2004; 86-B: 1118-23. 
[35] Hallan G, Lie SA, Furnes O, Engesaeter LB, Vollset SE, Havelin LI. Medium- and long-
term performance of 11 516 uncemented primary femoral stems from the 
Norwegian arthroplasty register. J Bone Joint Surg [Br] 2007;89-B:1574-80. 
[36] Gillespie W, Murray D, Gregg PJ, Warwick D. Risks and benefits of prophylaxis against 
venous thromboembolism in orthopaedic surgery. J Bone Joint Surg Br. 2000 
May;82(4):475-9. 
[37] Murray DW, Britton AR, Bulstrode CJ. Thromboprophylaxis and death after total  hip 
replacement. J Bone Joint Surg Br. 1996 Nov;78(6):863-70. 
[38] . Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. Ameta-
analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J 
Bone Joint Surg Am. 2000 Jul;82-A(7):929-38. 
[39] Beksaç B, González Della Valle A, Anderson J, Sharrock NE, Sculco TP, Salvato EA. 
Symptomatic thromboembolism after one-stage bilateral THA with a multimodal 
prophylaxis protocol. Clin Orthop Relat Res. 2007 Oct;463:114-9. 
[40] Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA. Potent anticoagulants 
are associated with a higher all-cause mortality rate after hip and knee 
arthroplasty. Clin Orthop Relat Res. 2008 Mar;466(3):714-21. 
[41] Jameson SS, Bottle A, Malviya A, Muller SD, Reed MR. The impact of national 
guidelines for the prophylaxis of venous thromboembolism on the complications of  
arthroplasty of the lower limb. J Bone Joint Surg Br. 2010 Jan;92(1):123-9 
[42] Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL. 
Failure of the American College of Chest Physicians-1A protocol for lovenox in 
clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007 Apr; 
22(3):317-24. 
www.intechopen.com
Recent Advances in Hip and Knee Arthroplasty
Edited by Dr. Samo Fokter
ISBN 978-953-307-841-0
Hard cover, 452 pages
Publisher InTech
Published online 27, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The purpose of this book is to offer an exhaustive overview of the recent insights into the state-of-the-art in
most performed arthroplasties of large joints of lower extremities. The treatment options in degenerative joint
disease have evolved very quickly. Many surgical procedures are quite different today than they were only five
years ago. In an effort to be comprehensive, this book addresses hip arthroplasty with special emphasis on
evolving minimally invasive surgical techniques. Some challenging topics in hip arthroplasty are covered in an
additional section. Particular attention is given to different designs of knee endoprostheses and soft tissue
balance. Special situations in knee arthroplasty are covered in a special section. Recent advances in computer
technology created the possibility for the routine use of navigation in knee arthroplasty and this remarkable
success is covered in depth as well. Each chapter includes current philosophies, techniques, and an extensive
review of the literature.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
N. A. Sandiford, U. Alao, J. A. Skinner and S. R. Samsani (2012). Hip Arthroplasty, Recent Advances in Hip
and Knee Arthroplasty, Dr. Samo Fokter (Ed.), ISBN: 978-953-307-841-0, InTech, Available from:
http://www.intechopen.com/books/recent-advances-in-hip-and-knee-arthroplasty/hip-arthroplasty
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
